These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2146102)
1. Platelet aggregation and disaggregation in the streptozotocin induced diabetic rat: the effect of sympathetic inhibition. Dunbar JC; Reinholt L; Henry RL; Mammen E Diabetes Res Clin Pract; 1990 Jul; 9(3):265-72. PubMed ID: 2146102 [TBL] [Abstract][Full Text] [Related]
2. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide. Judge S; Mammen E; Dunbar JC J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098 [TBL] [Abstract][Full Text] [Related]
3. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
4. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
5. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
6. Evidence that the rat is not an appropriate model to study the role of prostaglandins in normal or abnormal platelet aggregation. Huzoor-Akbar ; Anwer K Thromb Res; 1986 Feb; 41(4):555-66. PubMed ID: 3961734 [TBL] [Abstract][Full Text] [Related]
7. Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Paul W; Queen LR; Page CP; Ferro A Br J Pharmacol; 2007 Jan; 150(1):105-11. PubMed ID: 17099716 [TBL] [Abstract][Full Text] [Related]
8. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. Ersöz G; Yakaryilmaz A; Turan B Thromb Res; 2003; 111(6):363-7. PubMed ID: 14698654 [TBL] [Abstract][Full Text] [Related]
9. Experimental diabetes and platelet aggregation in the rat. Murray J; Kaneko JJ; Rucker RB Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254 [TBL] [Abstract][Full Text] [Related]
10. Altered platelet calsequestrin abundance, Na⁺/Ca²⁺ exchange and Ca²⁺ signaling responses with the progression of diabetes mellitus. Zheng Y; Wang L; Zhu Z; Yan X; Zhang L; Xu P; Luo D Thromb Res; 2014 Sep; 134(3):674-81. PubMed ID: 25084748 [TBL] [Abstract][Full Text] [Related]
11. In-vitro and ex-vivo inhibition of blood platelet aggregation by naftazone. Durand P; Bloy C; Peltier-Pujol F; Blache D J Pharm Pharmacol; 1996 Jun; 48(6):566-72. PubMed ID: 8832488 [TBL] [Abstract][Full Text] [Related]
12. Influence of adrenoceptor stimulation on aggregation of platelets from diabetic and control rats. Austin CE; Otter DJ; Chess-Williams R J Auton Pharmacol; 1995 Jun; 15(3):169-76. PubMed ID: 7673271 [TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding. Winocour PD; Perry DW; Kinlough-Rathbone RL Eur J Clin Invest; 1992 Jan; 22(1):19-23. PubMed ID: 1559539 [TBL] [Abstract][Full Text] [Related]
15. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539 [TBL] [Abstract][Full Text] [Related]
16. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193 [TBL] [Abstract][Full Text] [Related]
17. Effects of PP-56 and vitamin E on platelet hyperaggregability, fatty acid abnormalities, and clinical manifestations in streptozocin-induced diabetic rats. Ruf JC; Ciavatti M; Gustafsson T; Renaud S Diabetes; 1991 Feb; 40(2):233-9. PubMed ID: 1825073 [TBL] [Abstract][Full Text] [Related]
18. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Clowes AW; Karnovsky MJ Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of selenium and selenium with vitamin E on platelet functions in diabetic rats relationship to platelet sorbitol and fatty acid distribution. Douillet C; Bost M; Accominotti M; Borson-Chazot F; Ciavatti M Biol Trace Elem Res; 1996 Dec; 55(3):263-77. PubMed ID: 9096854 [TBL] [Abstract][Full Text] [Related]